http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TN-2016000529-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
filingDate 2015-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25b0920f874a95fcb224c792e338d494
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_093428dcf58787b095a0822d71aef3a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2913598811caee5f59b92b669bb79c22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db08e93699f53b558c00a2fb406388d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2147e887db63c4587e666ba8c4f36d7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ce737ef7f77c4e15fcb4fdd4294c0ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37eeb50853de84c30bd9aef782b7c972
publicationDate 2018-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TN-2016000529-A1
titleOfInvention Substituted dihydroisoquinolinone compounds
abstract This invention relates to compounds of general formula (I) in which R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, L, X and Z are as defined herein, and the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer.
priorityDate 2014-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56668956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426329550

Total number of triples: 32.